Treponema pallidum DNA (T. pallidum DNA)

Treponema pallidum DNA represents the entire genetic material of the spirochete bacterium responsible for syphilis, a chronic multi-stage infection. The genome is approximately 1.14 million base pairs long and is characterized by a lack of metabolic flexibility, making the organism an obligate human pathogen (Nature Reviews Microbiology, 2019). While the DNA itself is not a direct target for standard antibiotic therapies—which typically target the cell wall or protein synthesis machinery—it is the primary target for molecular diagnostic assays (StatPearls, 2023). Polymerase chain reaction (PCR) and other nucleic acid amplification tests (NAATs) target specific, highly conserved sequences within the T. pallidum DNA to provide a definitive diagnosis, particularly in cases where serological tests are inconclusive (CDC, 2021). Furthermore, the study of this DNA is essential for identifying molecular markers of antibiotic resistance, such as mutations in the 23S rRNA gene that confer resistance to macrolides (Journal of Clinical Microbiology, 2020). Genomic surveillance of T. pallidum DNA also helps track the epidemiology and evolution of different strains globally.

Other names

Treponema pallidum genomeSyphilis DNAT. pallidum nucleic acids

Not applicable as a direct therapeutic target; serves as a template for diagnostic nucleic acid amplification and genomic sequencing.